AORTARTIVION, INC.

NYSE artivion.com


$ 23.29 $ 0.00 (0 %)    

Tuesday, 14-May-2024 12:57:25 EDT
QQQ $ 443.60 $ -1.18 (-0.27 %)
DIA $ 394.32 $ -0.77 (-0.19 %)
SPY $ 520.95 $ -1.24 (-0.24 %)
TLT $ 90.75 $ 0.14 (0.15 %)
GLD $ 217.93 $ 0.09 (0.04 %)
$ 23.2
$ 23.29
$ 0.00 x 0
$ 0.00 x 0
$ 23.16 - $ 23.34
$ 12.16 - $ 25.51
146,852
na
1.11B
$ 1.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-19-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 03-09-2018 12-31-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 07-25-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 02-16-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 07-26-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-16-2016 12-31-2015 10-K
35 10-27-2015 09-30-2015 10-Q
36 07-28-2015 06-30-2015 10-Q
37 04-29-2015 03-31-2015 10-Q
38 02-17-2015 12-31-2014 10-K
39 10-28-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stifel-maintains-buy-on-artivion-raises-price-target-to-25

Stifel analyst Rick Wise maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $22 to $25.

 needham-maintains-buy-on-artivion-raises-price-target-to-30

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $25 to $30.

 artivion-revises-fy24-revenue-guidance-from-8-12-to-9-12-yy-growth-on-constant-currency-basis

The Company expects revenues to be in the range of $386 to $396 million compared to the previously articulated range of $382 to...

 artivion-q1-2024-adj-eps-006-beats-011-estimate-sales-97431m-beat-91978m-estimate

Artivion (NYSE:AORT) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.11) by 154...

 artivion-to-present-new-clinical-data-for-on-x-aortic-heart-valve-and-amds-at-104th-aats-annual-meeting

5-Year Real-World Safety and Efficacy Data from On-X Aortic Heart Valve Low INR Post-Market Study Demonstrate Even Better Patie...

 needham-maintains-buy-on-artivion-maintains-25-price-target

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and maintains $25 price target.

 why-doordash-shares-are-trading-lower-by-around-12-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of DoorDash, Inc. (NASDAQ: DASH) fell sharply in today’s session as the company reported mixed financial results for it...

 applied-materials-posts-upbeat-earnings-joins-texas-roadhouse-vulcan-materials-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.

 needham-maintains-buy-on-artivion-raises-price-target-to-25

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $22 to $25.

 artivion-sees-fy24-revenue-382m-396m-vs-38426m-est

2024 Financial OutlookThe Company expects revenues for the full year 2024 to be in the range of $382 to $396 million, represent...

 artivion-q4-eps-011-beats-010-estimate-sales-9367m-beat-8929m-estimate

Artivion (NYSE:AORT) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.10) by 210...

 earnings-scheduled-for-february-15-2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

 artivions-earnings-a-preview
Artivion's Earnings: A Preview
02/14/2024 15:02:21

 artivion-presents-data-from-amds-persevere-trial-a-60th-society-of-thoracic-surgery-annual-meeting

Full IDE Data Set Demonstrates Statistically Significant Reduction of All-Cause Mortality and Primary Major Adverse Events (MAE...

 most-suspicious-congressional-stock-trade-little-known-med-tech-firm-surges-48-in-just-2-months-after-senator-tina-smith-bought-the-dip

Sen. Tina Smith's (D-Minn.) controversial November investment yielded a 48% return within just two months.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION